These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11246679)

  • 1. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
    Gordon PA; Rosenthal E; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Feb; 28(2):366-9. PubMed ID: 11246679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.
    Brucato A; Frassi M; Franceschini F; Cimaz R; Faden D; Pisoni MP; Muscarà M; Vignati G; Stramba-Badiale M; Catelli L; Lojacono A; Cavazzana I; Ghirardello A; Vescovi F; Gambari PF; Doria A; Meroni PL; Tincani A
    Arthritis Rheum; 2001 Aug; 44(8):1832-5. PubMed ID: 11508435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.
    Gladman G; Silverman ED; Yuk-Law ; Luy L; Boutin C; Laskin C; Smallhorn JF
    Am J Perinatol; 2002 Feb; 19(2):73-80. PubMed ID: 11938480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Colombo G; Brucato A; Coluccio E; Compasso S; Luzzana C; Franceschini F; Quinzanini M; Scorza R
    Arthritis Rheum; 1999 Aug; 42(8):1757-64. PubMed ID: 10446878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.
    Spence D; Hornberger L; Hamilton R; Silverman ED
    J Rheumatol; 2006 Jan; 33(1):167-70. PubMed ID: 16292791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.
    Finkelstein Y; Adler Y; Harel L; Nussinovitch M; Youinou P
    Ann Med Interne (Paris); 1997; 148(3):205-8. PubMed ID: 9255327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report.
    Louthrenoo W; Boonyaratavej S; Sittiwangkul R; Sukitawut W
    J Med Assoc Thai; 1998 Aug; 81(8):633-6. PubMed ID: 9737117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
    Lazzerini PE; Capecchi PL; Guideri F; Bellisai F; Selvi E; Acampa M; Costa A; Maggio R; Garcia-Gonzalez E; Bisogno S; Morozzi G; Galeazzi M; Laghi-Pasini F
    Am J Cardiol; 2007 Sep; 100(6):1029-34. PubMed ID: 17826392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
    Costedoat-Chalumeau N; Amoura Z; Lupoglazoff JM; Huong DL; Denjoy I; Vauthier D; Sebbouh D; Fain O; Georgin-Lavialle S; Ghillani P; Musset L; Wechsler B; Duhaut P; Piette JC
    Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital complete heart block and maternal connective tissue disease.
    Jayaprasad N; Johnson F; Venugopal K
    Int J Cardiol; 2006 Sep; 112(2):153-8. PubMed ID: 16815568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
    Costa M; Gameiro Silva MB; Silva JA; Skare TL
    Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal lupus erythematosus complicated by improved congenital complete heart block.
    Isayama T; Inamura N; Shiono N; Kitajima H
    Pediatr Int; 2013 Aug; 55(4):521-4. PubMed ID: 23910804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal autoantibodies and fetal disease.
    Gross KR; Petty RE; Lum VL; Allen RC
    Clin Exp Rheumatol; 1989; 7(6):651-7. PubMed ID: 2612085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.
    Logar D; Kveder T; Rozman B; Dobovisek J
    Ann Rheum Dis; 1990 Aug; 49(8):627-9. PubMed ID: 2396870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background.
    Brucato A; Franceschini F; Gasparini M; De Juli E; Ferraro G; Quinzanini M; Vignati G; Bortolon C; Ghessi A; Pozzoli R
    J Rheumatol; 1995 Mar; 22(3):533-40. PubMed ID: 7783076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler fetal mechanical PR interval prolongation with positive maternal anti-RNP but negative SSA/Ro and SSB/La auto-antibodies.
    Acherman RJ; Friedman DM; Buyon JP; Schwartz J; Castillo WJ; Rollins RC; Evans WN
    Prenat Diagn; 2010 Aug; 30(8):797-9. PubMed ID: 20582918
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.